418 related articles for article (PubMed ID: 20940199)
1. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
4. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
7. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
[TBL] [Abstract][Full Text] [Related]
8. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
9. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.
Cahoon EK; Pfeiffer RM; Wheeler DC; Arhancet J; Lin SW; Alexander BH; Linet MS; Freedman DM
Int J Cancer; 2015 Mar; 136(5):E432-41. PubMed ID: 25258118
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous lymphomas in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A series of 12 cases.
Liu YA; Finn AJ; Subtil A
J Cutan Pathol; 2021 May; 48(5):617-624. PubMed ID: 33415780
[TBL] [Abstract][Full Text] [Related]
12. Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database.
Kim JS; Liu Y; Ha KH; Qiu H; Rothwell LA; Kim HC
Cancer Res Treat; 2020 Oct; 52(4):1262-1272. PubMed ID: 32599988
[TBL] [Abstract][Full Text] [Related]
13. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
Schonfeld SJ; Morton LM; Berrington de González A; Curtis RE; Kitahara CM
Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
[TBL] [Abstract][Full Text] [Related]
14. Composite Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Clinicopathological Study of Six Cases.
Jelloul FZ; Chen QH; Yang T; Haghi N; Brody J; Zhang X; Sheikh-Fayyaz S
Int J Surg Pathol; 2018 Apr; 26(2):135-144. PubMed ID: 29069998
[TBL] [Abstract][Full Text] [Related]
15. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
Mishra R; Dima D; Kumar SA; Mian A; Taneja A; Karna R; Caimi PF; Hill BT; Dean R; Jagadeesh D
Hematol Oncol; 2023 Dec; 41(5):884-893. PubMed ID: 37309225
[TBL] [Abstract][Full Text] [Related]
16. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis.
Rhee J; Birmann BM; De Roos AJ; Epstein MM; Martinez-Maza O; Breen EC; Magpantay LI; Levin LI; Visvanathan K; Hosgood HD; Rohan TE; Smoller SW; Bassig BA; Qi L; Shu XO; Koh WP; Zheng W; Yuan JM; Weinstein SJ; Albanes D; Lan Q; Rothman N; Purdue MP
Int J Cancer; 2023 Mar; 152(5):865-878. PubMed ID: 36151863
[TBL] [Abstract][Full Text] [Related]
18. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
[TBL] [Abstract][Full Text] [Related]
19. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
20. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
Jiang S; Zhen H; Jiang H
Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
